Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: results of two randomized studies

The aim of these studies (NCT01957163; NCT02119286) was to evaluate the efficacy and safety of umeclidinium (UMEC 62.5 μg and 125 μg) added to fluticasone furoate/vilanterol (FF/VI, 100/25 μg) in chronic obstructive pulmonary disease (COPD).

Source: Respiratory Medicine CME - June 13, 2015 Category: Respiratory Medicine Authors: Thomas M. Siler, Edward Kerwin, Ana R. Sousa, Alison Donald, Rehan Ali, Alison Church Source Type: research